Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Brain Imaging

Brain Imaging

Brain imaging technologies provide critical insights into both the structure and function of the human brain, enabling medical professionals and researchers to diagnose, study, and treat neurological disorders or psychiatric disorders more effectively.
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same authorSame journal

A molecular glue to take down mutant BRAF.

Science signaling·2026

Same author

In Science Journals.

Science (New York, N.Y.)·2026

Same author

Treating depression through G proteins.

Science signaling·2026

Same author

Sense and stromal density.

Science signaling·2026

Same author

In Science Journals.

Science (New York, N.Y.)·2026

Same author

In Science Journals.

Science (New York, N.Y.)·2026

Search research articles

Related Experiment Video

Updated: Feb 28, 2026

Processing of Primary Brain Tumor Tissue for Stem Cell Assays and Flow Sorting

Processing of Primary Brain Tumor Tissue for Stem Cell Assays and Flow Sorting

Published on: September 25, 2012

Detecting and treating brain cancer.

Leslie K Ferrarelli¹

¹Science Signaling, AAAS, Washington, DC 20005, USA.

Science Signaling

|June 15, 2017

Summary

Researchers used systems biology to find new blood biomarkers and drug targets for glioblastoma patients. This approach offers hope for improved diagnostics and treatments for this aggressive brain cancer.

Area of Science:

Biomedical research
Oncology
Systems biology

Background:

Glioblastoma is an aggressive brain tumor with poor prognosis.
Identifying reliable biomarkers and therapeutic targets is crucial for improving patient outcomes.

Purpose of the Study:

To identify novel plasma biomarkers for glioblastoma.
To discover potential therapeutic targets for glioblastoma treatment using a systems biology approach.

Main Methods:

Utilized a systems biology framework to analyze complex biological data.
Integrated multi-omics data to identify key molecular pathways and biomarkers.

Main Results:

Identified a panel of specific plasma biomarkers associated with glioblastoma.

More Related Videos

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells

Published on: August 2, 2022

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma

Published on: April 16, 2019

Related Experiment Videos

Last Updated: Feb 28, 2026

Processing of Primary Brain Tumor Tissue for Stem Cell Assays and Flow Sorting

Processing of Primary Brain Tumor Tissue for Stem Cell Assays and Flow Sorting

Published on: September 25, 2012

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells

Modeling Brain Metastasis by Internal Carotid Artery Injection of Cancer Cells

Published on: August 2, 2022

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma

Published on: April 16, 2019

Uncovered potential molecular targets for novel therapeutic interventions.

Conclusions:

The identified plasma biomarkers may aid in glioblastoma diagnosis and monitoring.
The discovered targets represent promising avenues for future glioblastoma drug development.